Altium Capital Management LP Oncternal Therapeutics, Inc. Transaction History

Altium Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$3.37 - $4.76 $580,374 - $819,757	-172,218 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$4.75 - $9.39 $19,327 - $38,207	-4,069 Reduced 2.31%	172,218 $818,000
Q1 2021 May 06, 2021	SELL	$4.59 - $9.04 $1.08 Million - $2.13 Million	-235,380 Reduced 57.18%	176,287 $1.47 Million
Q4 2020 Feb 16, 2021	BUY	$1.51 - $6.3 $621,617 - $2.59 Million	411,667 New	411,667 $2.02 Million

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $29.4M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Altium Capital Management LP with notifications on news.